{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:44:47Z","timestamp":1784047487040,"version":"3.55.0"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of chronic kidney disease (CKD) is increasing worldwide; black patients have an increased risk of developing CKD and end stage kidney disease (ESKD) at significantly higher rates than other races.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross sectional study was carried out on black patients with CKD attending the kidney outpatient clinic at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in South Africa,\n                      <jats:italic>between September 2019 to March 2020<\/jats:italic>\n                      . Demographic and clinical data were extracted from the ongoing kidney outpatient clinic records and interviews, and were filled in a questionnaire. Patients provided blood and urine for laboratory investigations as standard of care, and data were descriptively and inferentially entered into REDcap and analysed using STATA version 17. Multivariable logistic regression analysis was used to identify demographic and clinical variables associated with advanced CKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 312 black patients with CKD were enrolled in the study with a median age of 58 (IQR 46\u201367) years; 58% patients had advanced CKD, 31.5% of whom had grossly increased proteinuria, 96.7% had hypertension, 38.7% had diabetes mellitus and 38.1% had both hypertension and diabetes mellitus. In patients with advanced CKD, the median age was 61 (IQR 51\u201369) years, eGFR 33 (30\u201339) mL\/min\/1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , serum bicarbonate 22 (IQR 20\u201324), haemoglobin 12.9 (IQR 11.5\u201314.0) g\/dl and serum uric acid 0.43 (IQR 0.37\u20130.53). The prevalence of metabolic acidosis was 62.4%, anemia 46.4% and gout 30.9% among those with advanced CKD, while the prevalence of metabolic acidosis and anaemia was 46.6% and 25.9% respectively in those with early CKD. Variables with higher odds for advanced CKD after multivariable logistic regression analysis were hypertension (OR 3.3, 95% CI 1.2\u20139.2, P = 0.020), diabetes mellitus (OR 1.8, 95% CI 1.1\u20133.3, P = 0.024), severe proteinuria (OR 3.5, 95% CI 1.9\u20136.5, P = 0.001), angina (OR 2.5, 95% CI 1.2\u20135.1, P = 0.008), anaemia (OR 2.9, 95% CI 1.7\u20134.9, P = 0.001), hyperuricemia (OR 2.4, 95% CI 1.4\u20134.1, P = 0.001), and metabolic acidosis (OR 2.0, 95% CI 1.2\u20133.1, P = 0.005). Other associations with advanced CKD were loss of spouse (widow\/widower) (OR 3.2, 95% CI 1.4\u20137.4, P = 0.006), low transferrin (OR 2.4, 95% CI 1.1\u20135.1, P = 0.028), hyperkalemia (OR 5.4, 95% CI 1.2\u201324.1, P = 0.029), use of allopurinol (OR 2.4, 95% CI 1.4\u20134.3, P = 0.005) and doxazosin (OR 1.9, 95% CI 1.2\u20133.1, P = 0.006).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypertension and diabetes mellitus were strongly associated with advanced CKD, suggesting a need for primary and secondary population-based prevention measures. Metabolic acidosis, anemia with low transferrin levels, hyperuricemia and hyperkalemia were highly prevalent in our patients, including those with early CKD, and they were strongly associated with advanced CKD, requiring clinicians and dietitians to be proactive in supporting the needs of CKD patients in meeting their daily dietary requirements towards preventing and slowing the progression of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0266155","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T13:30:19Z","timestamp":1663594219000},"page":"e0266155","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Demographic and clinical profile of black patients with chronic kidney disease attending a tertiary hospital in Johannesburg, South Africa"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-7717","authenticated-orcid":true,"given":"Alfred","family":"Meremo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Paget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Dix-Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deogratius","family":"Bintabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-9725","authenticated-orcid":true,"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"issue":"1","key":"pone.0266155.ref001","doi-asserted-by":"crossref","first-page":"e015069","DOI":"10.1136\/bmjopen-2016-015069","article-title":"Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review","volume":"8","author":"S Abd ElHafeez","year":"2018","journal-title":"BMJ Open"},{"issue":"7","key":"pone.0266155.ref002","article-title":"Global Prevalence of Chronic Kidney Disease\u2013A Systematic Review and Meta-Analysis","volume":"11","author":"NR Hill","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"pone.0266155.ref003","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"JJ Carrero","year":"2018","journal-title":"Nature reviews Nephrology"},{"issue":"2","key":"pone.0266155.ref004","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kisu.2017.07.006","article-title":"Closing the gap between evidence and practice in chronic kidney disease","volume":"7","author":"MJ Jardine","year":"2017","journal-title":"Kidney International Supplements"},{"issue":"3","key":"pone.0266155.ref005","first-page":"363","article-title":"Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa","volume":"10","author":"AB Adeniyi","year":"2017","journal-title":"Clinical Kidney Journal"},{"issue":"3","key":"pone.0266155.ref006","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nefroe.2017.05.010","article-title":"Prevalence and risk of progression of chronic kidney disease in diabetics and hypertensive patients followed by primary care physicians","volume":"37","author":"G Alem\u00e1n-Vega","year":"2017","journal-title":"Nefrolog\u00eda (English Edition)."},{"issue":"12","key":"pone.0266155.ref007","doi-asserted-by":"crossref","first-page":"e1632","DOI":"10.1016\/S2214-109X(19)30443-7","article-title":"Kidney damage and associated risk factors in rural and urban sub-Saharan Africa (AWI-Gen): a cross-sectional population study","volume":"7","author":"JA George","year":"2019","journal-title":"The Lancet Global Health"},{"issue":"1","key":"pone.0266155.ref008","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-018-0930-5","article-title":"Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis","volume":"19","author":"AD Kaze","year":"2018","journal-title":"BMC Nephrol."},{"issue":"10","key":"pone.0266155.ref009","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/jch.13672","article-title":"Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study","volume":"21","author":"EK Tannor","year":"2019","journal-title":"Journal of clinical hypertension (Greenwich, Conn)."},{"issue":"5 Suppl 1","key":"pone.0266155.ref010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2018.06.021","article-title":"Kidney Disease Among African Americans: A Population Perspective","volume":"72","author":"M Laster","year":"2018","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"6","key":"pone.0266155.ref011","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.ajkd.2019.06.006","article-title":"Genetics and ESKD Disparities in African Americans. American journal of kidney diseases: the official journal of the","volume":"74","author":"EM Umeukeje","year":"2019","journal-title":"National Kidney Foundation"},{"issue":"3","key":"pone.0266155.ref012","doi-asserted-by":"crossref","first-page":"e020145","DOI":"10.1136\/bmjopen-2017-020145","article-title":"Ethnic differences in the progression of chronic kidney disease and risk of death in a UK diabetic population: an observational cohort study","volume":"8","author":"R Mathur","year":"2018","journal-title":"BMJ open"},{"issue":"7","key":"pone.0266155.ref013","first-page":"e9499","article-title":"Survival of the Fittest: Addressing the Disparities in the Burden of Chronic Kidney Disease","volume":"12","author":"ML Nelson","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"pone.0266155.ref014","doi-asserted-by":"crossref","first-page":"e0193384","DOI":"10.1371\/journal.pone.0193384","article-title":"Performance of glomerular filtration rate estimation equations in Congolese healthy adults: The inopportunity of the ethnic correction","volume":"13","author":"JB Bukabau","year":"2018","journal-title":"PLoS ONE"},{"issue":"9","key":"pone.0266155.ref015","doi-asserted-by":"crossref","first-page":"e2127014","DOI":"10.1001\/jamanetworkopen.2021.27014","article-title":"Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012\u20132019","volume":"4","author":"CD Chu","year":"2021","journal-title":"JAMA network open"},{"key":"pone.0266155.ref016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nefro.2017.04.006","article-title":"Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass","volume":"38","author":"I Gal\u00e1n","year":"2018","journal-title":"Nefrolog\u00eda (Madrid)"},{"issue":"2","key":"pone.0266155.ref017","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000488816","article-title":"Disorders of Lipid Metabolism in Chronic Kidney Disease","volume":"46","author":"MC Bulbul","year":"2018","journal-title":"Blood Purification"},{"issue":"1","key":"pone.0266155.ref018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.ajkd.2020.08.005","article-title":"Assessing Acid-Base Status in Patients With CKD: Does Measurement of Blood pH Matter?","volume":"77","author":"KL Raphael","year":"2021","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"pone.0266155.ref019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-020-01852-3","article-title":"Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review","volume":"21","author":"HO Hounkpatin","year":"2020","journal-title":"BMC Nephrology"},{"issue":"4","key":"pone.0266155.ref020","doi-asserted-by":"crossref","first-page":"e0230980","DOI":"10.1371\/journal.pone.0230980","article-title":"Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?","volume":"15","author":"S Alagoz","year":"2020","journal-title":"PloS one"},{"key":"pone.0266155.ref021","volume-title":"StatPearls","author":"H Shaikh","year":"2022"},{"issue":"4","key":"pone.0266155.ref022","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000464260","article-title":"Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function","volume":"45","author":"M Kuwabara","year":"2017","journal-title":"American Journal of Nephrology"},{"issue":"6","key":"pone.0266155.ref023","doi-asserted-by":"crossref","first-page":"0300060520919224","DOI":"10.1177\/0300060520919224","article-title":"A retrospective cross-sectional study of the associated factors of hyperuricemia in patients with chronic kidney disease","volume":"48","author":"L-P Guo","year":"2020","journal-title":"Journal of International Medical Research"},{"issue":"5","key":"pone.0266155.ref024","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.nefroe.2019.10.001","article-title":"Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease","volume":"39","author":"F Caravaca-Font\u00e1n","year":"2019","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"Suppl 1","key":"pone.0266155.ref025","doi-asserted-by":"crossref","first-page":"s31","DOI":"10.1590\/1806-9282.66.s1.31","article-title":"Hyperkalemia in chronic kidney disease","volume":"66Suppl 1","author":"R. Watanabe","year":"2020","journal-title":"Revista da Associacao Medica Brasileira (1992)"},{"key":"pone.0266155.ref026","article-title":"Health Survey for England 2016: adult health trends","author":"NS Research","year":"2017","journal-title":"Health and Social Care Information Centre London"},{"issue":"8","key":"pone.0266155.ref027","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2215\/CJN.12791019","article-title":"Kidney Disease, Race, and GFR Estimation","volume":"15","author":"AS Levey","year":"2020","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"pone.0266155.ref028","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"PA Harris","year":"2019","journal-title":"Journal of biomedical informatics"},{"issue":"2","key":"pone.0266155.ref029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"Journal of biomedical informatics"},{"key":"pone.0266155.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S292522","article-title":"How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice","volume":"17","author":"E Polychronopoulou","year":"2021","journal-title":"Vascular health and risk management"},{"issue":"10","key":"pone.0266155.ref031","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11906-020-01081-x","article-title":"Resistant Hypertension in Chronic Kidney Disease (CKD): Prevalence, Treatment Particularities, and Research Agenda","volume":"22","author":"PI Georgianos","year":"2020","journal-title":"Current hypertension reports"},{"issue":"12","key":"pone.0266155.ref032","doi-asserted-by":"crossref","first-page":"e1587","DOI":"10.1016\/S2214-109X(19)30467-X","article-title":"Chronic kidney disease in sub-Saharan Africa","volume":"7","author":"TE Matsha","year":"2019","journal-title":"The Lancet Global Health"},{"issue":"4","key":"pone.0266155.ref033","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40265-019-1064-1","article-title":"Management of Hypertension in Chronic Kidney Disease","volume":"79","author":"D Pugh","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"pone.0266155.ref034","doi-asserted-by":"crossref","first-page":"204","DOI":"10.34067\/KID.0007792021","article-title":"Hypertension Pharmacogenomics in CKD: The Clinical Relevance and Public Health Implications","volume":"3","author":"TT Geng","year":"2022","journal-title":"Kidney360"},{"issue":"5","key":"pone.0266155.ref035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2215\/CJN.04330418","article-title":"Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD","volume":"14","author":"AD Sinha","year":"2019","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"2","key":"pone.0266155.ref036","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.ajkd.2020.07.018","article-title":"Kidney, Cardiac, and Safety Outcomes Associated With \u03b1-Blockers in Patients With CKD: A Population-Based Cohort Study","volume":"77","author":"GL Hundemer","year":"2021","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"3","key":"pone.0266155.ref037","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States","volume":"73","author":"R Saran","year":"2019","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"pone.0266155.ref038","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1038\/s41598-020-63443-4","article-title":"Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice","volume":"10","author":"J Jitraknatee","year":"2020","journal-title":"Scientific Reports"},{"issue":"2","key":"pone.0266155.ref039","doi-asserted-by":"crossref","first-page":"e0246509","DOI":"10.1371\/journal.pone.0246509","article-title":"Prevalence and associated factors of impaired renal function and albuminuria among adult patients admitted to a hospital in Northeast Ethiopia","volume":"16","author":"T Fiseha","year":"2021","journal-title":"PloS one"},{"issue":"5","key":"pone.0266155.ref040","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ekir.2018.04.008","article-title":"Renal Outcomes of Antidiabetic Treatment Options for Type 2 Diabetes\u2014A Proposed MARE Definition","volume":".3","author":"FC Prischl","year":"2018","journal-title":"Kidney International Reports"},{"issue":"17","key":"pone.0266155.ref041","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1161\/CIR.0000000000000920","article-title":"Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association","volume":"142","author":"J Rangaswami","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"pone.0266155.ref042","first-page":"452","article-title":"Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment","volume":"7","author":"M Adamczak","year":"2021","journal-title":"Kidney diseases (Basel, Switzerland)"},{"issue":"10","key":"pone.0266155.ref043","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1007\/s12325-021-01886-5","article-title":"Prevalence of Metabolic Acidosis Among Patients with Chronic Kidney Disease and Hyperkalemia","volume":"38","author":"EE Cook","year":"2021","journal-title":"Advances in therapy"},{"issue":"2","key":"pone.0266155.ref044","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.xkme.2020.12.006","article-title":"Metabolic Acidosis in CKD: A Review of Recent Findings","volume":"3","author":"ML Melamed","year":"2021","journal-title":"Kidney medicine"},{"issue":"5","key":"pone.0266155.ref045","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.xkme.2021.04.011","article-title":"Metabolic Acidosis and Cardiovascular Disease in CKD","volume":"3","author":"D Collister","year":"2021","journal-title":"Kidney medicine"},{"issue":"3","key":"pone.0266155.ref046","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.jrn.2020.08.001","article-title":"Treatment of Chronic Kidney Disease-Related Metabolic Acidosis With Fruits and Vegetables Compared to NaHCO(3) Yields More and Better Overall Health Outcomes and at Comparable Five-Year Cost","volume":"31","author":"N Goraya","year":"2021","journal-title":"Journal of renal nutrition: the official journal of the Council on Renal Nutrition of the National Kidney Foundation"},{"issue":"9","key":"pone.0266155.ref047","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093277","article-title":"Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease","volume":"13","author":"T Naber","year":"2021","journal-title":"Nutrients"},{"key":"pone.0266155.ref048","doi-asserted-by":"crossref","first-page":"642296","DOI":"10.3389\/fmed.2021.642296","article-title":"Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents","volume":"8","author":"J Portol\u00e9s","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"pone.0266155.ref049","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000516901","article-title":"Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents","volume":"52","author":"MR Weir","year":"2021","journal-title":"Am J Nephrol."},{"key":"pone.0266155.ref050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/IJNRD.S179802","article-title":"Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa","volume":"12","author":"AM Nalado","year":"2019","journal-title":"International journal of nephrology and renovascular disease"},{"issue":"8","key":"pone.0266155.ref051","doi-asserted-by":"crossref","first-page":"e031550","DOI":"10.1136\/bmjopen-2019-031550","article-title":"Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study","volume":"9","author":"AG Stack","year":"2019","journal-title":"BMJ open"},{"issue":"1","key":"pone.0266155.ref052","doi-asserted-by":"crossref","first-page":"e0210487","DOI":"10.1371\/journal.pone.0210487","article-title":"Prevalence and treatment of gout among patients with chronic kidney disease in the Irish health system: A national study","volume":"14","author":"E Mohammed","year":"2019","journal-title":"PloS one"},{"key":"pone.0266155.ref053","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000484288","article-title":"Treatment of Hyperuricemia in Chronic Kidney Disease","volume":"192","author":"JC Ramirez-Sandoval","year":"2018","journal-title":"Contributions to nephrology"},{"key":"pone.0266155.ref054","doi-asserted-by":"crossref","first-page":"653634","DOI":"10.3389\/fmed.2021.653634","article-title":"Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options","volume":"8","author":"E Morales","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"pone.0266155.ref055","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.18553\/jmcp.2021.27.10.1403","article-title":"Association of dyskalemias with short-term health care utilization in patients with advanced CKD","volume":"27","author":"AA Dashputre","year":"2021","journal-title":"Journal of managed care & specialty pharmacy"},{"issue":"11","key":"pone.0266155.ref056","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular Disease in Chronic Kidney Disease","volume":"143","author":"J Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"pone.0266155.ref057","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41598-020-80877-y","article-title":"Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease","volume":"11","author":"H Ryu","year":"2021","journal-title":"Scientific Reports"},{"issue":"14","key":"pone.0266155.ref058","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review","volume":"74","author":"MJ Sarnak","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"122","key":"pone.0266155.ref059","article-title":"Prevalence of Proteinuria and Albuminuria in an Obese Population and Associated Risk Factors","volume":"5","author":"JL Rosenstock","year":"2018","journal-title":"Frontiers in Medicine"},{"issue":"6","key":"pone.0266155.ref060","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.kint.2018.01.008","article-title":"Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe","volume":"93","author":"K Br\u00fcck","year":"2018","journal-title":"Kidney international"},{"issue":"11","key":"pone.0266155.ref061","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.mayocp.2019.09.014","article-title":"How Do We Navigate the Complexities Surrounding the Use of Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers in Chronic Kidney Disease?","volume":"94","author":"S Bhandari","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"issue":"19","key":"pone.0266155.ref062","doi-asserted-by":"crossref","first-page":"e009992","DOI":"10.1161\/JAHA.118.009992","article-title":"Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin\u2010Converting Enzyme Inhibitors and Angiotensin Receptor Blockers","volume":".7","author":"E Ku","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"pone.0266155.ref063","article-title":"Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study","author":"SJ Leon","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"pone.0266155.ref064","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1038\/s41598-019-38991-z","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population","volume":"9","author":"C-M Zheng","year":"2019","journal-title":"Scientific Reports"},{"issue":"8","key":"pone.0266155.ref065","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-020-01290-3","article-title":"ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3\u20135: A Network Meta-Analysis of Randomised Clinical Trials","volume":"80","author":"Y Zhang","year":"2020","journal-title":"Drugs"},{"issue":"12","key":"pone.0266155.ref066","doi-asserted-by":"crossref","first-page":"e0188975","DOI":"10.1371\/journal.pone.0188975","article-title":"Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis","volume":"12","author":"Y-C Lin","year":"2017","journal-title":"PloS one"},{"issue":"5","key":"pone.0266155.ref067","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2020.10.006","article-title":"Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.","volume":"77","author":"EL Fu","year":"2021","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:05:57Z","timestamp":1728000357000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266155"}},"subtitle":[],"editor":[{"given":"Kanhaiya","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266155","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.16.22272477","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}